Conference "Improving Health Through Science and Innovation from Aragon" on June 19

The IIS Aragón and the PERTE Commissioner Vanguard Health, in collaboration with the Ibercaja Foundation, They are organizing a day open to the public where topics such as precision medicine, new advanced therapies, and the role of biobanks will be discussed. in Aragon, among others

Next Thursday 19 June el Aragón Health Research Institute (IIS Aragón) and the PERTE Health Commissioner of Vanguardia, in collaboration with Ibercaja Foundation, organized in the Patio of the Infanta a session open to the public to discover how Aragon is leading the way in precision medicine, clinical trials, and industrial innovation with the goal of improving people's health and quality of life. 

During this day, the following will be taught: five short lectures followed by a brief discussion. With language accessible to all audiences, topics will include precision medicine, new advanced therapies, the role of biobanks, and the importance of early-phase trials with a focus on their development in Aragon. In addition, we will have the vision of a testimonial patient.

The activity is Delivery to Italy takes one or two business days. Places are limited and the registration It is done through the following link.

Programme

18:XNUMX a.m. Welcome: 

• Dr. Jose Luis Bancalero. Health Minister of the Government of Aragon.
• Dr. Rachel Yotti. Commissioner of the PERTE of Health.
• D. José Luis Rodrigo Escrig. Managing Director of the Ibercaja Foundation.

18:15 p.m. Presentations:

Ángel Lanas. Scientific Director of the IIS Aragón.

Alberto J. Schuhmacher. ARAID-IIS Aragón Researcher.

Precision medicine. Medicine for people.

• Dr. Alberto J. Schuhmacher. ARAID Researcher. Coordinator of the Immunity, Cancer, and Infectious Diseases Program at the IIS Aragón.

Biobanks, allies in translational research.

• Dr. Delia Recalde.Technical Coordinator of the Biobank of the Aragon Health System (BSSA). Aragon Institute of Health Sciences.

Gene therapy, cell therapy, tissue engineering. Present and future.

• Dr. Diego Sánchez Martínez. Coordinator of the Scientific Area of ​​Advanced Therapies at the IIS Aragón.

The importance of early-phase clinical trials for opting for the most innovative cancer therapies. 

• Dr. Roberto Pazo Cid. Specialist Physician. Oncology Assistant at the Miguel Servet University Hospital.

The vision and voice of patients. 

• Cesar Perez Leon. Patient and Volunteer testimonial of the Spanish Association Against Cancer.

19 p.m. Final debate moderated by: Raquel Yotti and Ángel Lanas.

Source: Ibercaja Foundation